MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Identification of barriers preventing disclosure of non-motor symptoms in Parkinson’s patients to healthcare providers

    C.S. Hurt, L. Rixon, K.R. Chaudhuri, R. Moss-Morris, M. Samuel, R.G. Brown (London, United Kingdom)

    Objective: 1) To identify patient barriers to help-seeking for non-motor symptoms (NMS) from their Parkinson's healthcare provider, 2) To determine whether barriers are symptom specific…
  • 2016 International Congress

    Identification of premotor Parkinson’s disease

    K.C. Hughes, X. Gao, M.A. Schwarzschild, A. Ascherio (Boston, MA, USA)

    Objective: To evaluate the prevalence of and associations between potential markers of premotor Parkinson's disease (PD) and to estimate the relative risk of these markers…
  • 2016 International Congress

    Head and trunk control during stair ascent and descent in people with Parkinson’s disease

    Z.J. Conway, P.A. Silburn, T.D. Blackmore, M.H. Cole (Brisbane, Australia)

    Objective: This cross-sectional study investigated whether people with Parkinson's disease (PD) demonstrate differences in head and trunk control during self-paced stair ascent and descent compared…
  • 2016 International Congress

    Prevalence of Parkinson’s disease and myotonic dystrophy in the nomadic population: Mongolian study

    T. Sosorburam, B. Samdan, J. Amar (Ulan-Bator, Mongolia)

    Objective: To determine the prevalence of Parkinson's disease (PD) and Myotonic Dystrophy (MD) in the isolated people, where a study never been conducted before regarding…
  • 2016 International Congress

    Parkinson’s in an aging population: Implications from a nation-wide prevalence and incidence study in New Zealand

    D.J. Myall, T.L. Pitcher, M.R. MacAskill, J.F. Pearson, C.J. Lacey, J.C. Dalrymple-Alford, T.J. Anderson (Christchurch, New Zealand)

    Objective: To estimate the national prevalence and incidence of Parkinson's as a function of age and the implications this has on future disease burden. Background:…
  • 2016 International Congress

    Cancer comorbidity among PD patients; a population based large-scale cohort study

    R. Gurel, N. Giladi, V. Rozani, T. Gurevich, B. El-Ad, B. Hemo, J. Tsamir, C. Peretz (Tel Aviv, Israel)

    Objective: To estimate the risk of incident cancer; any type and specific types‎ in PD (Parkinson's disease) patients, by sex; and to compare it to…
  • 2016 International Congress

    Dystonia in a medieval scribe: Analysis of Bernard Blancard’s handwriting over four decades

    D.E. Thorpe, N. Melson, J.E. Alty (York, United Kingdom)

    Objective: We evaluate the dated documents of a French scribe, which span the late 13th and early 14th centuries, in order to reach a diagnosis…
  • 2016 International Congress

    Meaningful life attitudes support positive coping in patients with idiopathic Parkinson’s disease

    S. Gräber, J. Meinhardt, E. Schäffer, A. Apel, D. Berg (Tübingen, Germany)

    Objective: To evaluate factors differentiating positive (good active coping, GAC) from poor (poor active coping, PAC) coping behavior regarding their disease in idiopathic Parkinson's disease…
  • 2016 International Congress

    Are people with Parkinson’s disease living in care homes in the UK underserved? Identifying models of care and barriers to care access

    L.L. Oates, A. Hand, R.W. Walker, W.K. Gray, P. Reynolds, L. Cockram (North Shields, United Kingdom)

    Objective: To conduct a nationwide online survey of Parkinson's disease nurse specialists (PDNS) and Parkinson's UK information staff to gain insight into current models of…
  • 2016 International Congress

    Evaluation of stigmatization and quality of life before and after botulinum toxin treatment in hemifacial spasm

    B. Yuksel, F. Genc, A. Yaman, P. Dogan Ak, E. Ozaydin Goksu, A. Aybar, Y. Bicer Gomceli (Antalya, Turkey)

    Objective: Hemifacial spasm (HFS) is a chronic disease that is characterized by involuntary tonic and clonic contractions of the muscles innervated by the ipsilateral facial…
  • « Previous Page
  • 1
  • …
  • 97
  • 98
  • 99
  • 100
  • 101
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley